FDA
approval
· 2024-01-03
FDA Approved: MARLISSA — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approves a supplemental application for MARLISSA (levonorgestrel and ethinyl estradiol) submitted by Glenmark Pharmaceuticals Inc., USA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MARLISSA (LEVONORGESTREL AND ETHINYL ESTRADIOL)